Generate Biomedicines plans up to $425 million U.S. IPO

Go back to Generate Biomedicines plans up to $425 million U.S. IPO
(NASDAQ: GENB) Delayed: 15.72 +0.33 (2.14%)
Previous Close $15.39    52 Week High
Open $15.44    52 Week Low
Day High $15.88    P/E N/A 
Day Low $15.32    EPS
Volume 666,177